Drupal.behaviors.print = function(context) {window.print();window.close();}>
Marina Preps for Additional Patient Enrollment in FAP Trial, Predicts Pharma Partnership This Year
January 26, 2012
Marina Preps for Additional Patient Enrollment in FAP Trial, Predicts Pharma Partnership This Year
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Mirna Becomes First to Advance Therapeutic microRNA Mimic into Human Testing
May 2, 2013 / Gene Silencing News
Mirna Reports Preclinical Data on Lead miRNA Replacement Drug, Focusing on Upcoming Phase I
January 24, 2013 / Gene Silencing News
Debiopharm Drops Out of Bladder Cancer Deal with Cash-Strapped Marina
November 15, 2012 / Gene Silencing News
NIH Awards $1.2M in Grants to Four Companies Developing RNAi, miRNA Cancer Drugs
October 4, 2012 / Gene Silencing News
Ag-Bio Firms Increasingly Look to RNAi, microRNAs through Partnerships
May 24, 2012 / Gene Silencing News